重药控股(000950.SZ)拟收购天士营销及陕西天士力物流
格隆汇12月16日丨重药控股(000950.SZ)公布,公司控股子公司重庆医药(集团)股份有限公司(“重庆医药”)与天士力医药集团股份有限公司(“天士力”)等8位交易对方签署了《关于收购天津天士力医药营销集团股份有限公司及陕西天士力医药物流有限公司股权的框架协议》,该协议仅为双方对资产交易事项的初步意向,并非最终交易方案,具体交易方案仍需要进一步论证和沟通协商。
根据《框架协议》,在天津天士力医药营销集团股份有限公司(“天士营销”)完成相关业务剥离的前提下,重庆医药拟通过支付现金对价的方式收购天士营销98.32%股权;因目前天士营销正在进行摘牌,天士营销摘牌完成后将由天士力对其他股东进行股份回购,天士力在客观条件许可的情况下将全部回购。天士力回购完成后,重庆医药将购买其所回购天士营销全部股权。
另外,重庆医药将购买天士力控股持有的陕西天士力医药物流有限公司(“陕西天士力物流”)100%股权。
天士营销主要负责天士力的医药商业业务板块,陕西天士力物流是一家专业的医药三方物流公司,为医药健康产业供应链上下游提供专业三方物流服务;通过此次资产收购,公司将有效拓展销售区域,加快公司推进全国性网络布局的步伐,为公司实现“走向全国”的战略目标打下坚实基础。同时,公司拟通过此次交易与天士力在医药商业领域建立长期良好的合作关系,最终实现合作共赢的战略目标。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.